Last Updated: February, 2026
Trusted by 200+ Clients
Compare & Choose the Right Report Version for You
How to Order Your Report?
The report provides a detailed analysis essential for establishing a cisatracurium besylate production plant. It encompasses all critical aspects necessary for cisatracurium besylate production, including the cost of cisatracurium besylate production, cisatracurium besylate plant cost, cisatracurium besylate production costs, and the overall cisatracurium besylate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a cisatracurium besylate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Cisatracurium Besylate is a muscle relaxant mainly used in hospitals during surgeries and critical care. It is primarily utilized as a muscle relaxant during general anaesthesia to help doctors perform surgeries more safely and smoothly. It is primarily used adjunctively in general anaesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It helps relax the muscles by blocking nerve signals, which makes it easier for doctors to insert breathing tubes and perform procedures that require the patient to stay still. It also finds its application in assisting with endotracheal intubation, where a breathing tube is inserted into the patient’s airway. Moreover, it is also widely used in intensive care units (ICUs) to support patients who require mechanical ventilation, as it helps relax the muscles and improve breathing control. It is also known for having fewer side effects compared to similar medicines, which makes it a preferred choice in patients with liver or kidney problems.
The market for cisatracurium besylate is driven by its application as a neuromuscular blocking agent for endotracheal intubation and other surgical procedures, which boosts its demand in the medical sector. Its application for relaxing muscles during anaesthesia helps with breathing tube insertion and supports controlled ventilation, further contributing to its demand in the intensive care settings and pharmaceutical industries. Its usage during general anaesthesia and in patients on ventilators in intensive care units significantly drives its demand in hospitals and surgical settings. Its demand as a potent muscle relaxant in various critical care procedures, where controlled muscle relaxation is essential, further promotes its market growth.
Its broad usage in modern anaesthesia and emergency care to ensure safe muscle management during complex medical treatments significantly boosts its demand in the medical and healthcare sectors. Additionally, industrial cisatracurium besylate procurement is influenced by the cost and availability of raw materials, regulatory approvals across major markets, and adherence to safety and handling protocols. Advancements in synthesis techniques, consistency in quality standards, reliable contract production, and strong supply chain operations further shape its global procurement strategies.
According to the cisatracurium besylate production plant project report, the major raw materials for cisatracurium besylate production includes 1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinoline.
The extensive cisatracurium besylate production cost report consists of the following industrial production process:
Cisatracurium Besylate is the benzenesulfonate salt form of cisatracurium, and it acts as a non-depolarising neuromuscular blocking agent of the benzylisoquinolinium class. It appears as a white to off-white solid powder that is soluble in water. The molecular formula of the compound is C65H82N2O18S2, and its molar mass is 1243.49 g/mol. The compound has low lipid solubility, with a log partition coefficient of −2.12 in a 1-octanol/distilled water system at 25 °C. The compound has a melting point in the range of approximately 90–102 °C. It is one of the ten isomers of atracurium besylate, constituting approximately 15% of that mixture, and it possesses approximately three to five times the neuromuscular blocking potency of atracurium. The compound is classified under GHS as Acute Toxicity Category 3 (Oral), indicating it is toxic if swallowed, and it is also irritating to the eyes. It is recommended to wear protective clothing and safety glasses while handling the compound. It is sold under the brand name Nimbex.
Cisatracurium Besylate Production Cost Report
Choose What's Right for You
Pay Via
| Particulars | Details |
|---|---|
| Product Name | Cisatracurium Besylate |
| Scope | Production Process: Process Flow, Material Flow, Material Balance Raw Material and Product Specifications: Raw Material Consumption, Product and Co-product Generation Land and Site Cost: Offsites/Civil Works, Equipment Cost, Auxiliary Equipment Costs, Contingency, Engineering and Consulting Charges, Working Capital Variable Cost: Raw Material, Utilities, Other Variable Costs Fixed Cost: Labor Requirements and Wages, Overhead Expenses, Maintenance Charges, Other Fixed Costs Financing Costs: Interest on Working Capital, Interest on Loans Other Costs: Depreciation Charges, General Sales and Admin Cost |
| Currency | US$ (Data can also be provided in the local currency) |
| Pricing and Purchase Options | Basic: US$ 2499 Premium: US$ 3499 Enterprise: US$ 4799 |
| Customization Scope | The report can be customized as per the requirement of the customer |
| Post-Sale Analysts Report | 10-12 weeks of post-purchase analyst support after report delivery for any queries from the deliverable |
| Delivery Format | PDF and Excel format through email (editable version in PPT/Word format of the report can be also provided on special request) |
At Procurement Resource, we not only focus on optimizing the should cost of production for cisatracurium besylate but also provide our clients with extensive intel and rigorous information on every aspect of the production process. By utilizing a comprehensive cost model, we help you break down expenses related to raw materials, labor, and technology, offering clear pathways to savings. We also assist in evaluating the capital expenditure (CAPEX) and operating expenses (OPEX), which are often measured as cost per unit of production, such as USD/MT, ensuring that your financial planning is aligned with industry benchmarks.
We offer valuable insights on the top technology providers, in-depth supplier database, and best manufacturers, helping you make informed decisions to improve efficiency. Additionally, we design the most feasible layout for your production needs, ensuring the entire process runs smoothly. By minimizing the cash cost of production, we ensure that you stay competitive while securing long-term profitability in the growing cisatracurium besylate market. Partnering with Procurement Resource guarantees that every aspect of your production is cost-efficient, advanced, and tailored to your specific requirements.
Lead - Social & Development Research
Delivering procurement intelligence and supply chain analytics across healthcare, FMCG, and chemicals sectors, with expertise in cost modeling, vendor mapping, and spend optimization to support data-driven sourcing decisions and procurement outcomes.
Need more help?
Still Need Help?
